The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with a rising ageing population, increased demand for minimally invasive procedures, and growth in health care spending is the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market.
Key Market Trends
The Computerized Tomography (CT) Segment Led the Global Market in 2018
Imaging studies are used in ischemic diagnosis for the detection of haemorrhage in the acute stroke patient, in order to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit.
Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy.
In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyperacute phase, a non-contrast CT (NCCT) scan is usually ordered to exclude or confirm haemorrhage; it is highly sensitive for this indication.
North America Holds the Largest Market Share
By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa (MEA), and South America. North America is the largest market for acute ischemic stroke diagnosis devices and is estimated to continue its stronghold of the market, owing to favourable government initiatives, technological innovations, and increasing demand for ischemic stroke products.
Asia-Pacific is expected to be the fastest-growing market for acute ischemic stroke diagnosis, owing to the increasing incidences of ischemic stroke cases in the region. Manufacturers are expanding their operations in the Asia-Pacific region, as these regions hold immense potential for market growth.
The leading vendors of acute ischemic stroke diagnosis products are expanding their operations in Asian countries (India, China, Japan, and South Korea), as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. Major players operating in the global acute ischemic stroke diagnosis and treatment market include Agilent Technologies, Johnson and Johnson, Bio-Rad Laboratories, and Abbott Laboratories.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support